Persistent Asset Partners’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-115
Closed -$2.36K – 406
2025
Q3
$2.36K Buy
+115
New +$13.8K ﹤0.01% 229

Other funds holding JAZZ

Persistent Asset Partners's JAZZ Position: Q3 2026 in Review

Persistent Asset Partners reduced its Jazz Pharmaceuticals (JAZZ) stake by 47% in Q3 2026, selling an estimated $136K and leaving 612 shares worth $142K. The position accounts for 0.04% of the portfolio, ranked #246.

Persistent Asset Partners first reported a position in JAZZ in Q1 2025 and has held it in 7 quarters since. The position peaked at $3.01M in Q1 2026. 670 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

  • Persistent Asset Partners held 612 shares of Jazz Pharmaceuticals worth $142K as of Q3 2026.
  • Persistent Asset Partners sold 552 Jazz Pharmaceuticals shares in Q3 2026, an estimated $136K.
  • Jazz Pharmaceuticals made up 0.04% of Persistent Asset Partners's portfolio in Q3 2026, its #246 holding.
  • Persistent Asset Partners first reported a position in Jazz Pharmaceuticals in Q1 2025 and has held it in 7 quarters since.
  • Persistent Asset Partners's Jazz Pharmaceuticals position peaked at $3.01M in Q1 2026.
  • 670 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on Persistent Asset Partners's 13F filing for Q3 2026, filed 13 Nov 2026.